Cargando…

SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer

BACKGROUND: Radioresistance is the common cause for radiotherapy failure in non-small cell lung cancer (NSCLC), and the degree of radiosensitivity of tumor cells is different during different cell cycle phases. The objective of the present study was to investigate the effects of cell cycle redistrib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Rubo, Ding, Qian, Li, Pindong, Xue, Jun, Zou, Zhenwei, Huang, Jing, Peng, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723552/ https://www.ncbi.nlm.nih.gov/pubmed/23842094 http://dx.doi.org/10.1186/1748-717X-8-178

Ejemplares similares

Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma
por: Peng, Gang, et al.
Publicado: (2014)

Increased SHP-1 expression results in radioresistance, inhibition of cellular senescence, and cell cycle redistribution in nasopharyngeal carcinoma cells
por: Sun, Ziyi, et al.
Publicado: (2015)

Apatinib enhances the radiosensitivity of the esophageal cancer cell line KYSE-150 by inducing apoptosis and cell cycle redistribution
por: Hu, Lijun, et al.
Publicado: (2019)

Kinetics of mouse jejunum radiosensitization by 2′,2′-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells
Publicado: (1998)

Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.
por: GrÃ©goire, V., et al.
Publicado: (1997)

Alterations of cell cycle control proteins SHP-1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells
por: PENG, GANG, et al.
Publicado: (2014)

miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1
por: Ke, Yang, et al.
Publicado: (2013)

RSF-1 siRNA Enhances Tumor Radiosensitivity in Cervical Cancer via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis
por: Tian, Jing, et al.
Publicado: (2020)

Inhibition of PC4 radiosensitizes non‐small cell lung cancer by transcriptionally suppressing XLF
por: Zhang, Tian, et al.
Publicado: (2018)

Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer
por: Li, Qianwen, et al.
Publicado: (2017)

Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests
por: Kriegs, Malte, et al.
Publicado: (2016)

GLUT-1 siRNA Enhances Radiosensitization Of Laryngeal Cancer Stem Cells Via Enhanced DNA Damage, Cell Cycle Redistribution, And Promotion Of Apoptosis In Vitro And In Vivo
por: Zhong, Jiang-Tao, et al.
Publicado: (2019)

Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated
por: Park, Soo-Yeon, et al.
Publicado: (2010)

GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer
por: Ren, Jialin, et al.
Publicado: (2018)

Interferon inhibits the redistribution of cell surface components
Publicado: (1980)

Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines
por: Liu, Ningbo, et al.
Publicado: (2019)

Inhibition of SENP1 induces radiosensitization in lung cancer cells
por: WANG, RUO-TIAN, et al.
Publicado: (2013)

Lymphocyte Cell-Cycle Inhibition by HLA-G Is Mediated by Phosphatase SHP-2 and Acts on the mTOR Pathway
por: Ketroussi, Farah, et al.
Publicado: (2011)

Sidestepping SHP2 inhibition
por: Popescu, Bogdan, et al.
Publicado: (2023)

Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells
por: Hu, Chenxi, et al.
Publicado: (2019)

OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair
por: Wu, Zhiqiang, et al.
Publicado: (2019)

Preclinical studies for improving radiosensitivity of non-small cell lung cancer cell lines by combining glutaminase inhibition and senolysis
por: Fujimoto, Masaki, et al.
Publicado: (2022)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Bufalin inhibits epithelial-mesenchymal transition and increases radiosensitivity of non-small cell lung cancer via inhibition of the Src signaling
por: Wang, Zijian, et al.
Publicado: (2023)

Increased activation of cGAS‐STING pathway enhances radiosensitivity of non‐small cell lung cancer cells
por: Xue, Aiying, et al.
Publicado: (2022)

Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer
por: Chen, Xu, et al.
Publicado: (2016)

A novel role for apatinib in enhancing radiosensitivity in non-small cell lung cancer cells by suppressing the AKT and ERK pathways
por: Li, Lin, et al.
Publicado: (2021)

Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells [Retraction]
Publicado: (2022)

Elevated BTG2 improves the radiosensitivity of non‐small cell lung cancer (NSCLC) through apoptosis
por: Zhu, Changchun, et al.
Publicado: (2022)

BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
por: Kong, Yangyang, et al.
Publicado: (2022)

Radiosensitivity in Non-Small-Cell Lung Cancer by MMP10 through the DNA Damage Repair Pathway
por: Bi, Yawei, et al.
Publicado: (2023)

MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line
por: Ma, Debin, et al.
Publicado: (2015)

The prognostic significance of SHP2 and its binding protein Hook1 in non-small cell lung cancer
por: He, Lingjuan, et al.
Publicado: (2019)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022)

Diminished Functional Role and Altered Localization of Shp2 in Non-Small Cell Lung Cancer Cells With Egfr-Activating Mutations
por: Furcht, Christopher M., et al.
Publicado: (2012)

Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
por: Cron, Kyle R., et al.
Publicado: (2013)

Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer
por: Xu, Qiushi, et al.
Publicado: (2022)

Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer
por: Cunningham, Charnay, et al.
Publicado: (2023)

Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3
por: Qi, Chen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g8oifd1fjeij7nmh3bt4d1bs4j